Patent 9771568 was granted and assigned to Novozymes on September, 2017 by the United States Patent and Trademark Office.
Provided are isolated polypeptides having beta-glucosidase activity and polynucleotides encoding the polypeptides. Also provided are nucleic acid constructs, vectors and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.